Jazz Pharmaceuticals (JAZZ) 131.75 $JAZZ
Technical Summary on Pharma Stocks -- Research on Salix Pharma, Nektar Therapeutics, Corcept Therapeutics, and Jazz Pharma
PR Newswire - Mon May 12, 11:30AM CDT
The US markets saw a positive sentiment on Friday, May 9, 2014, with the NASDAQ Composite closing at 4,071.87, up 0.50%, the Dow Jones Industrial Average ending the session 0.20% higher at 16,583.34, and the S&P 500 edging 0.15% higher to finish the trading session at 1,878.48. The gains were broad based as six out of the ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 668.35, up 0.58%, with the index advancing 3.66% in the last one month. Investor-Edge has initiated coverage on the following equities: Salix Pharmaceuticals Ltd (NASDAQ: SLXP), Nektar Therapeutics (NASDAQ: NKTR), Corcept Therapeutics Inc. (NASDAQ: CORT) and Jazz Pharmaceuticals PLC (NASDAQ: JAZZ). Free technical research on SLXP, NKTR, CORT and JAZZ can be downloaded upon signing up at:
Ariad Pharmaceuticals, Inc Earnings: Cloudy Future Drains Enthusiasm
Leo Sun, The Motley Fool - Motley Fool - Mon May 12, 9:20AM CDT
Shares of Ariad Pharmaceuticals fell nearly 5% on May 7 after the company reported its first-quarter earnings. The stock has fallen more than 60% over the past 12 months due to safety concerns about its only...
Why Jazz Pharmaceuticals Inc. Shares Briefly Tumbled
Sean Williams, The Motley Fool - Motley Fool - Fri May 09, 4:16PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Jazz Pharmaceuticals , a specialty...
SmarTrend Watching for Potential Rebound in Shares of Jazz Pharmaceuticals After 3.17% Loss
Comtex SmarTrend(R) - Fri May 09, 3:42PM CDT
Jazz Pharmaceuticals (NASDAQ:JAZZ) traded in a range yesterday that spanned from a low of $120.38 to a high of $129.76. Yesterday, the shares fell 3.2%, which took the trading range below the 3-day low of $133.04 on volume of 3.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Stocks Close Higher After Late Boost; Air Lease Gains
at Investor's Business Daily - Fri May 09, 3:34PM CDT
Stocks struggled for direction but ultimately ended modestly higher on Friday after some late-session strength. The Nasdaq climbed 0.5%, while the Dow Jones industrial average and the S&P 500 edged up 0.2%. According to preliminary data, volume fell...
Ralph Lauren and Netflix are big market movers
AP - Fri May 09, 3:30PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
Stocks Fall Moderately; Nasdaq Nears Long-Term Support
at Investor's Business Daily - Fri May 09, 10:48AM CDT
Losses were mild for the major averages about two hours into Friday's session, but below the surface, growth stocks continued to face selling pressure. The Nasdaq lost 0.4%, the S&P 500 gave up 0.3% and the Dow Jones industrial average eased 0.2%. In...
Jim Cramer's Stop Trading: Jazz Pharmaceuticals Faces Music
at The Street - Fri May 09, 10:06AM CDT
Cramer notes that Jazz Pharmaceuticals missed estimates but likes how WhiteWave Foods beat expectations.
Earnings Up at Jazz Pharma, Guidance Reiterated - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri May 09, 8:40AM CDT
Jazz Pharmaceuticals reported first quarter 2014 adjusted (including stock-based compensation expense and depreciation) earnings of $1.51 per share.
Stock Futures Point Lower; Ubiquiti, Jazz Under Pressure
at Investor's Business Daily - Fri May 09, 8:11AM CDT
Stock futures steered lower Friday as investors navigated a steady stream of earnings reports and a rising dollar. Dow futures traded 25 points below fair market value. Nasdaq 100 futures were off 11 points and S&P 500 futures dipped 3 points. The...
Health Care Stocks to Watch Today: Amarin Corporation plc, Jazz Pharmaceuticals, and Vanda Pharmaceu
George Budwell, The Motley Fool - Motley Fool - Fri May 09, 8:00AM CDT
Let's take a look at today's top stories in biotech and health care. Keep an eye out for Amarin , Jazz Pharmaceuticals and Vanda Pharmaceuticals . Amarin reports first-quarter earnings The much-maligned biotech Amarin reported...
Jazz Pharmaceuticals Announces First Quarter 2014 Financial Results
PR Newswire Europe - Thu May 08, 3:36PM CDT
-- Company Reports First Quarter 2014 Total Revenues of $247 Million Driven by Strong Sales of Xyrem, Erwinaze and Defibrotide
Stocks Hold Solid Gains; WhiteWave Surges On Earnings
at Investor's Business Daily - Thu May 08, 12:34PM CDT
Major averages were firmly in positive territory just past the midway point of Thursday's trading. The Nasdaq fell off session highs but still rose 0.5%. The Dow Jones industrial average also gained 0.5% while the S&P 500 added 0.4%. Volume on the...
Valeant Q1 Mixed, But Strong 2014 Guidance Affirmed
at Investor's Business Daily - Thu May 08, 10:19AM CDT
Canadian drugmaker Valeant Pharmaceuticals International (VRX) reported a mixed but mostly in-line Q1 Thursday, as management continued to press its case for a merger with Allergan (AGN). Valeant's stock rose fractionally on the stock market today....
Today's Top Health Care Stocks to Watch: Depomed Inc., Dendreon Corp., and Jazz Pharmaceuticals
George Budwell, The Motley Fool - Motley Fool - Thu May 08, 8:00AM CDT
Let's take a look at today's top stories in biotech and health care. Keep an eye out for Depomed , Dendreon , and Jazz Pharmaceuticals . Depomed to report first-quarter earnings today The biopharma world will likely take a keen interest in...
SmarTrend Watching for Potential Pullback in Shares of Jazz Pharmaceuticals After 1.69% Gain
Comtex SmarTrend(R) - Mon May 05, 5:52PM CDT
Jazz Pharmaceuticals (NASDAQ:JAZZ) traded in a range yesterday that spanned from a low of $137.00 to a high of $142.91. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $140.00 on volume of 471,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Ubiquiti, Avis Budget Among 5 IBD 50 Stocks Reporting
at Investor's Business Daily - Sat May 03, 7:02AM CDT
As the market works through correction, new leaders are positioning to shoot out of the gate when they get a green light. Few leaders race to the front of the pack without passing through the IBD 50 list of top-rated stocks. Today's IBD 50 includes a...
AstraZeneca Nixes New Bid As Pfizer Woos British PM
at Investor's Business Daily - Fri May 02, 1:11PM CDT
British big pharma AstraZeneca (AZN) turned down a second takeover bid from U.S. counterpart Pfizer (PFE) Friday, saying that the $106 billion offer was still too low. Pfizer's stock dropped nearly 2%, while AstraZeneca's held steady on the stock...
Esteemed Recognitions, Upcoming Conferences, and Solid Quarterly Results - Analyst Notes on Medtronic, Baxter, LabCorp, Jazz Pharmaceuticals and ResMed
PR Newswire - Fri May 02, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Medtronic, Inc. (NYSE: MDT), Baxter International Inc. (NYSE: BAX), Laboratory Corp. of America Holdings (NYSE: LH), Jazz Pharmaceuticals plc (NASDAQ: JAZZ) and ResMed Inc. (NYSE: RMD). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1943-100free.
Technical Summary on Pharma Stocks -- Research on Salix Pharma, Nektar Therapeutics, Corcept Therapeutics, and Jazz Pharma
PR Newswire - Mon May 12, 11:30AM CDT
The US markets saw a positive sentiment on Friday, May 9, 2014, with the NASDAQ Composite closing at 4,071.87, up 0.50%, the Dow Jones Industrial Average ending the session 0.20% higher at 16,583.34, and the S&P 500 edging 0.15% higher to finish the trading session at 1,878.48. The gains were broad based as six out of the ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 668.35, up 0.58%, with the index advancing 3.66% in the last one month. Investor-Edge has initiated coverage on the following equities: Salix Pharmaceuticals Ltd (NASDAQ: SLXP), Nektar Therapeutics (NASDAQ: NKTR), Corcept Therapeutics Inc. (NASDAQ: CORT) and Jazz Pharmaceuticals PLC (NASDAQ: JAZZ). Free technical research on SLXP, NKTR, CORT and JAZZ can be downloaded upon signing up at:
Ariad Pharmaceuticals, Inc Earnings: Cloudy Future Drains Enthusiasm
Leo Sun, The Motley Fool - Motley Fool - Mon May 12, 9:20AM CDT
Shares of Ariad Pharmaceuticals fell nearly 5% on May 7 after the company reported its first-quarter earnings. The stock has fallen more than 60% over the past 12 months due to safety concerns about its only...
Why Jazz Pharmaceuticals Inc. Shares Briefly Tumbled
Sean Williams, The Motley Fool - Motley Fool - Fri May 09, 4:16PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Jazz Pharmaceuticals , a specialty...
SmarTrend Watching for Potential Rebound in Shares of Jazz Pharmaceuticals After 3.17% Loss
Comtex SmarTrend(R) - Fri May 09, 3:42PM CDT
Jazz Pharmaceuticals (NASDAQ:JAZZ) traded in a range yesterday that spanned from a low of $120.38 to a high of $129.76. Yesterday, the shares fell 3.2%, which took the trading range below the 3-day low of $133.04 on volume of 3.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Stocks Close Higher After Late Boost; Air Lease Gains
at Investor's Business Daily - Fri May 09, 3:34PM CDT
Stocks struggled for direction but ultimately ended modestly higher on Friday after some late-session strength. The Nasdaq climbed 0.5%, while the Dow Jones industrial average and the S&P 500 edged up 0.2%. According to preliminary data, volume fell...
Ralph Lauren and Netflix are big market movers
AP - Fri May 09, 3:30PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
Stocks Fall Moderately; Nasdaq Nears Long-Term Support
at Investor's Business Daily - Fri May 09, 10:48AM CDT
Losses were mild for the major averages about two hours into Friday's session, but below the surface, growth stocks continued to face selling pressure. The Nasdaq lost 0.4%, the S&P 500 gave up 0.3% and the Dow Jones industrial average eased 0.2%. In...
Jim Cramer's Stop Trading: Jazz Pharmaceuticals Faces Music
at The Street - Fri May 09, 10:06AM CDT
Cramer notes that Jazz Pharmaceuticals missed estimates but likes how WhiteWave Foods beat expectations.
Earnings Up at Jazz Pharma, Guidance Reiterated - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri May 09, 8:40AM CDT
Jazz Pharmaceuticals reported first quarter 2014 adjusted (including stock-based compensation expense and depreciation) earnings of $1.51 per share.
Stock Futures Point Lower; Ubiquiti, Jazz Under Pressure
at Investor's Business Daily - Fri May 09, 8:11AM CDT
Stock futures steered lower Friday as investors navigated a steady stream of earnings reports and a rising dollar. Dow futures traded 25 points below fair market value. Nasdaq 100 futures were off 11 points and S&P 500 futures dipped 3 points. The...
Health Care Stocks to Watch Today: Amarin Corporation plc, Jazz Pharmaceuticals, and Vanda Pharmaceu
George Budwell, The Motley Fool - Motley Fool - Fri May 09, 8:00AM CDT
Let's take a look at today's top stories in biotech and health care. Keep an eye out for Amarin , Jazz Pharmaceuticals and Vanda Pharmaceuticals . Amarin reports first-quarter earnings The much-maligned biotech Amarin reported...
Jazz Pharmaceuticals Announces First Quarter 2014 Financial Results
PR Newswire Europe - Thu May 08, 3:36PM CDT
-- Company Reports First Quarter 2014 Total Revenues of $247 Million Driven by Strong Sales of Xyrem, Erwinaze and Defibrotide
Stocks Hold Solid Gains; WhiteWave Surges On Earnings
at Investor's Business Daily - Thu May 08, 12:34PM CDT
Major averages were firmly in positive territory just past the midway point of Thursday's trading. The Nasdaq fell off session highs but still rose 0.5%. The Dow Jones industrial average also gained 0.5% while the S&P 500 added 0.4%. Volume on the...
Valeant Q1 Mixed, But Strong 2014 Guidance Affirmed
at Investor's Business Daily - Thu May 08, 10:19AM CDT
Canadian drugmaker Valeant Pharmaceuticals International (VRX) reported a mixed but mostly in-line Q1 Thursday, as management continued to press its case for a merger with Allergan (AGN). Valeant's stock rose fractionally on the stock market today....
Today's Top Health Care Stocks to Watch: Depomed Inc., Dendreon Corp., and Jazz Pharmaceuticals
George Budwell, The Motley Fool - Motley Fool - Thu May 08, 8:00AM CDT
Let's take a look at today's top stories in biotech and health care. Keep an eye out for Depomed , Dendreon , and Jazz Pharmaceuticals . Depomed to report first-quarter earnings today The biopharma world will likely take a keen interest in...
SmarTrend Watching for Potential Pullback in Shares of Jazz Pharmaceuticals After 1.69% Gain
Comtex SmarTrend(R) - Mon May 05, 5:52PM CDT
Jazz Pharmaceuticals (NASDAQ:JAZZ) traded in a range yesterday that spanned from a low of $137.00 to a high of $142.91. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $140.00 on volume of 471,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Ubiquiti, Avis Budget Among 5 IBD 50 Stocks Reporting
at Investor's Business Daily - Sat May 03, 7:02AM CDT
As the market works through correction, new leaders are positioning to shoot out of the gate when they get a green light. Few leaders race to the front of the pack without passing through the IBD 50 list of top-rated stocks. Today's IBD 50 includes a...
AstraZeneca Nixes New Bid As Pfizer Woos British PM
at Investor's Business Daily - Fri May 02, 1:11PM CDT
British big pharma AstraZeneca (AZN) turned down a second takeover bid from U.S. counterpart Pfizer (PFE) Friday, saying that the $106 billion offer was still too low. Pfizer's stock dropped nearly 2%, while AstraZeneca's held steady on the stock...
Esteemed Recognitions, Upcoming Conferences, and Solid Quarterly Results - Analyst Notes on Medtronic, Baxter, LabCorp, Jazz Pharmaceuticals and ResMed
PR Newswire - Fri May 02, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Medtronic, Inc. (NYSE: MDT), Baxter International Inc. (NYSE: BAX), Laboratory Corp. of America Holdings (NYSE: LH), Jazz Pharmaceuticals plc (NASDAQ: JAZZ) and ResMed Inc. (NYSE: RMD). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1943-100free.
